QbDVision, an Austin, TX-based SaaS solution purpose-built for drug lifecycle management provider, raised $15M in Series A funding.
The round was led by Northpond Ventures, with participation from S3 Ventures, Wanxiang Healthcare Investments, and Hudson Park Capital.
This round of funding brings the total capital raised to $20M which will drive expansion of a commercial market that already includes a wide range of enterprise pharma, biotech, and CDMO customers across the world.
Led by CEO Yash Sabharwal, QbDVision is a digital CMC workspace, a cloud-based SaaS solution designed to enhance the curation, utilization, and integrity of process development data to accelerate therapies to patients. Developed by a team of drug development experts, QbDVision creates a structured digital framework for integrating CMC workflows, embedding best practices for process design, and managing product and process knowledge.
